Sector: Health Care
Director information for EDWARDS LIFESCIENCES CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Annette M. Brüls | Corporate Vice President, Europe, Middle East, Africa, Canada and Latin America (EMEACLA) | 54 | ["More than 25 years of experience leading diverse teams", "Former CEO of Medela Inc.", "Held senior leadership positions at Medtronic plc and Abbott Vascular"] | ["Compensation and Nominating Committee"] | 2026 |
| Bernard Zovighian | Chief Executive Officer, Edwards Lifesciences Corporation; CEO; Director and Chief Executive Officer | 58 | ["Chief Executive Officer at Edwards Lifesciences Corporation since 2023", "President from January 2023 to May 2023", "Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies (TMTT) from 2018 to 2023", "Vice President then Corporate Vice President, Surgical Structural Heart from 2015 to 2018", "Held various roles at Johnson & Johnson for nearly 20 years, including worldwide President of one of the company's divisions", "Expert in strategy development and disruptive technologies in medical technology"] | [] | 2026 |
| David T. Feinberg, MD | Chairman, Oracle Health, Inc. | 64 | ["Chairman of Oracle Health since 2022", "President and Chief Executive Officer of Oracle Health from 2021 to 2022", "Vice President of Google Health from 2019 to 2021", "President and Chief Executive Officer of Geisinger Health Systems from 2015 to 2019", "President and Chief Executive Officer of UCLA Health from 2011 to 2019", "Director of Nashville Health Care Council since 2024", "Experience in health system and health information technology services management", "Patient-centric mindset and expertise in guiding systems transformations"] | ["Audit Committee"] | 2026 |
| Kieran T. Gallahue | Former Chairman and CEO, CareFusion Corporation | 62 | ["Chairman and Chief Executive Officer at CareFusion Corporation", "Chief Executive Officer at ResMed Inc.", "Various positions including President and Chief Financial Officer at Nanogen Inc.", "Board and Executive Committee member of AdvaMed"] | ["Audit Committee Member"] | 2026 |
| Leslie C. Davis | CEO and President, University of Pittsburgh Medical Center | 67 | ["More than 30 years of experience in health care", "Chief Executive Officer experience", "Experience in operations at large health services organizations", "Insights into healthcare challenges and opportunities"] | ["Compensation and Governance Committee Member"] | 2026 |
| Leslie S. Heisz | Former Managing Director, Lazard Frères & Co; Chair of the Audit Committee | 65 | ["Member of the Board of Kaiser Foundation Hospitals and Kaiser Foundation Health Plan, Inc.", "Senior Advisor and Managing Director at Lazard Fr\u00e8res & Co.", "Director and Managing Director at Dresdner Kleinwort Wasserstein Securities Limited", "Vice President, Corporate Finance at Salomon Brothers Inc.", "Staff Consultant and Senior Consultant at PricewaterhouseCoopers LLP"] | ["Audit Committee"] | 2026 |
| Nicholas J. Valeriani | Former CEO, Gary and Mary West Health Institute Former EVP, Johnson & Johnson | 69 | ["Former CEO of Gary and Mary West Health Institute", "Former EVP at Johnson & Johnson", "Chair of the Compensation Committee at Surgalign Holdings, Inc.", "Experienced in medical technology industry for more than 40 years"] | ["Compensation and Governance Committee"] | 2026 |
| Paul A. LaViolette | CEO, Pulse Biosciences, Inc., Managing Partner and COO, SV Health Investors LLC; Chair of the Compensation and Governance Committee | 68 | ["Over 40 years in the medical technology industry", "Extensive global executive experience", "Experience in strategy and innovation", "Operations management", "Human capital resources", "Marketing and communications", "Corporate strategy and corporate governance", "Experience in serving on other boards and chairmanships"] | ["Compensation and Governance Committee"] | 2026 |
| Ramona Sequeira | Former President, Global Portfolio Division, Takeda Pharmaceutical Company; Director | 60 | ["Over 25 years of experience in the pharmaceutical industry", "Led Takeda\u2019s Global Portfolio Division", "Experience in finance, mergers and acquisitions, innovation and technology, risk management and oversight, corporate responsibility, sustainability, and human capital resources"] | ["Audit Committee"] | 2026 |
| Steven R. Loranger | Former Chairman, President and CEO, ITT Corporation | 74 | ["Executive with global manufacturing and operational experience", "Expertise in risk management and oversight", "Experience in operations management, financial reporting, finance", "Expertise in innovations and technology and corporate strategy", "Knowledge of cybersecurity and information technology"] | ["Compensation and Governance Committee"] | 2026 |
